Diagnostic and prognostic values of the mRNA expression of excision repair cross-complementation enzymes in hepatitis B virus-related hepatocellular carcinoma

References

• ChenWZhengRBaadePDCancer statistics in China, 2015CA Cancer J Clin201666211513226808342
   PubMed Web of Science ®Google Scholar
• TangDNaganoHNakamuraMClinical and pathological features of Allen’s type C classification of resected combined hepatocellular and cholangiocarcinoma: a comparative study with hepatocellular carcinoma and cholangiocellular carcinomaJ Gastrointest Surg200610798799816843869
   PubMed Web of Science ®Google Scholar
• MckillopIHMoranDMJinXKoniarisLGMolecular pathogenesis of hepatocellular carcinomaJ Surg Res2006136112513517023002
   PubMed Web of Science ®Google Scholar
• PangRTseEPoonRTMolecular pathways in hepatocellular carcinomaCancer Lett2006240215716916239065
   PubMed Web of Science ®Google Scholar
• JungSWParkNHShinJWPolymorphisms of DNA repair genes in Korean hepatocellular carcinoma patients with chronic hepatitis B: possible implications on survivalJ Hepatol201257362162722659345
   PubMed Web of Science ®Google Scholar
• Le MayNEglyJ-MCoinFTrue lies: the double life of the nucleotide excision repair factors in transcription and DNA repairJ Nucleic Acids20102010110
   Google Scholar
• HouSMFältSAngeliniSThe XPD variant alleles are associated with increased aromatic DNA adduct level and lung cancer riskCarcinogenesis200223459960311960912
   PubMed Web of Science ®Google Scholar
• KarahalilBBohrVAWilsonDMImpact of DNA polymorphisms in key DNA base excision repair proteins on cancer riskHum Exp Toxicol20123110981100523023028
   PubMed Web of Science ®Google Scholar
• ZhaoMLiSZhouLShenQZhuHZhuXPrognostic values of excision repair cross-complementing genes mRNA expression in ovarian cancer patientsLife Sci2018194343929247747
   PubMed Web of Science ®Google Scholar
• QinXYaoWLiWERCC1 and BRCA1 mRNA expressions are associated with clinical outcome of non-small cell lung cancer treated with platinum-based chemotherapyTumour Biol20143554697470424443257
   PubMedGoogle Scholar
• SunJMAhnMJParkMJExpression of excision repair cross-complementation group 1 as predictive marker for nasopharyngeal cancer treated with concurrent chemoradiotherapyInt J Rad Oncol Biol Phys2011803655660
   PubMed Web of Science ®Google Scholar
• GrimmingerPPShiMBarrettCTS and ERCC-1 mRNA expressions and clinical outcome in patients with metastatic colon cancer in CONFIRM-1 and -2 clinical trialsPharmacogenomics J201212540441121788964
   PubMed Web of Science ®Google Scholar
• LiLMZengXYJiL[Association of XPC and XPG polymorphisms with the risk of hepatocellular carcinoma] XPC hé XPG duō tài xìng yǔ gān xìbāo ái fēngxiǎn de guānxìZhonghua Gan Zang Bing Za Zhi2010184271275 Chinese20460046
   PubMedGoogle Scholar
• SakuradaTYoshikawaMSunagaMExpression of drug-resistant factor genes in hepatocellular carcinoma patients undergoing chemotherapy with platinum complex by arterial infusionPharmaceutics20102330031227721358
   PubMedGoogle Scholar
• YoonAJKuoWHLinCWYangSFRole of ERCC5 polymorphism in risk of hepatocellular carcinomaOncol Lett20112591191422866149
   PubMed Web of Science ®Google Scholar
• RoesslerSLongELBudhuAIntegrative genomic identification of genes on 8p associated with hepatocellular carcinoma progression and patient survivalGastroenterology2012142495796622202459
   PubMed Web of Science ®Google Scholar
• RoesslerSJiaHLBudhuAA unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patientsCancer Res20107024102021021221159642
   PubMed Web of Science ®Google Scholar
• ShaulYDYuanBThiruPMERAV: a tool for comparing gene expression across human tissues and cell typesNucleic Acids Res201644D1D560D56626626150
   PubMed Web of Science ®Google Scholar
• LiaoXHuangKHuangRGenome-scale analysis to identify prognostic markers in patients with early-stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomyOnco Targets Ther2017104493450628979141
   PubMed Web of Science ®Google Scholar
• LiaoXHuangRLiuXDistinct prognostic values of alcohol dehydrogenase mRNA expression in pancreatic adenocarcinomaOnco Targets Ther2017103719373228769575
   PubMed Web of Science ®Google Scholar
• LiaoXLiuXYangCDistinct diagnostic and prognostic values of minichromosome maintenance gene expression in patients with hepatocellular carcinomaJ Cancer20189132357237330026832
   PubMed Web of Science ®Google Scholar
• HuangRLiaoXLiQIdentification and validation of potential prognostic gene biomarkers for predicting survival in patients with acute myeloid leukemiaOnco Targets Ther2017105243525429138577
   PubMed Web of Science ®Google Scholar
• LiaoXZhuGHuangRIdentification of potential prognostic microRNA biomarkers for predicting survival in patients with hepatocellular carcinomaCancer Manag Res20181078780329713196
   PubMed Web of Science ®Google Scholar
• LiaoXYangCHuangRIdentification of potential prognostic long non-coding RNA biomarkers for predicting survival in patients with hepatocellular carcinomaCell Physiol Biochem20184851854186930092592
   PubMedGoogle Scholar
• SubramanianATamayoPMoothaVKGene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profilesProc Natl Acad Sci200510243155451555016199517
   PubMed Web of Science ®Google Scholar
• MoothaVKLindgrenCMErikssonKFPGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetesNat Genet200334326727312808457
   PubMed Web of Science ®Google Scholar
• LiberzonABirgerCThorvaldsdóttirHGhandiMMesirovJPTamayoPThe Molecular Signatures Database (MSigDB) hallmark gene set collectionCell Syst20151641742526771021
   PubMed Web of Science ®Google Scholar
• DennisGShermanBTHosackDADAVID: Database for Annotation, Visualization, and Integrated DiscoveryGenome Biol200345P312734009
   PubMed Web of Science ®Google Scholar
• HuangDawShermanBTLempickiRASystematic and integrative analysis of large gene lists using DAVID bioinformatics resourcesNat Protoc200941445719131956
   PubMed Web of Science ®Google Scholar
• QiuLWangZShiXWangZAssociations between XPC polymorphisms and risk of cancers: a meta-analysisEur J Cancer200844152241225318771913
   PubMed Web of Science ®Google Scholar
• García-ClosasMMalatsNRealFXGenetic variation in the nucleotide excision repair pathway and bladder cancer riskCancer Epidemiol Biomarkers Prev200615353654216537713
   PubMed Web of Science ®Google Scholar
• LiCYinMWangLEPolymorphisms of nucleotide excision repair genes predict melanoma survivalJ Invest Dermatol201313371813182123407396
   PubMed Web of Science ®Google Scholar
• MatakidouAEl GaltaRWebbELGenetic variation in the DNA repair genes is predictive of outcome in lung cancerHum Mol Genet200716192333234017855454
   PubMed Web of Science ®Google Scholar
• SchöffskiPTaronMJimenoJPredictive impact of DNA repair functionality on clinical outcome of advanced sarcoma patients treated with trabectedin: a retrospective multicentric studyEur J Cancer20114771006101221376569
   PubMed Web of Science ®Google Scholar
• SunXLiFSunNPolymorphisms in XRCC1 and XPG and response to platinum-based chemotherapy in advanced non-small cell lung cancer patientsLung Cancer200965223023619157633
   PubMed Web of Science ®Google Scholar
• KweekelDMAntoniniNFNortierJWPuntCJGelderblomHGuchelaarHJExplorative study to identify novel candidate genes related to oxaliplatin efficacy and toxicity using a DNA repair arrayBr J Cancer2009101235736219536092
   PubMed Web of Science ®Google Scholar
• SongXSturgisEMJinLWangZWeiQLiGVariants in nucleotide excision repair core genes and susceptibility to recurrence of squamous cell carcinoma of the oropharynxInt J Cancer2013133369570423335232
   PubMed Web of Science ®Google Scholar
• GoyalSParikhRRGreenCClinicopathologic significance of excision repair cross-complementation 1 expression in patients treated with breast-conserving surgery and radiation therapyInt J Rad Oncol, Biol, Phys2010763679684
   PubMed Web of Science ®Google Scholar
• SasakiSWatanabeTNakayamaHAnalysis of the mRNA expression of chemotherapy-related genes in colorectal carcinoma using the Danenberg tumor profile methodJ Oncol20132013386906386906723577026
   PubMedGoogle Scholar
• BănescuCIancuMTrifaAPInfluence of XPC, XPD, XPF, and XPG gene polymorphisms on the risk and the outcome of acute myeloid leukemia in a Romanian populationTumour Biol20163779357936626779634
   PubMedGoogle Scholar
• StromSSEsteyEOutschoornUMGarcia-ManeroGAcute myeloid leukemia outcome: role of nucleotide excision repair polymorphisms in intermediate risk patientsLeuk Lymphoma201051459860520141440
   PubMed Web of Science ®Google Scholar
• CuiYMorgensternHGreenlandSPolymorphism of Xeroderma Pigmentosum group G and the risk of lung cancer and squamous cell carcinomas of the oropharynx, larynx and esophagusInt J Cancer2006118371472016094634
   PubMed Web of Science ®Google Scholar
• MaHYuHLiuZWangLESturgisEMWeiQPolymorphisms of XPG/ERCC5 and risk of squamous cell carcinoma of the head and neckPharmacogenet Genomics2012221505722108238
   PubMed Web of Science ®Google Scholar
• ZhangXJLiuPZhuFPolymorphisms of DNA repair-related genes with susceptibility and prognosis of prostate cancerGenet Mol Res20141324419442424615090
   PubMed Web of Science ®Google Scholar
• SakanoSKumarRLarssonPA single-nucleotide polymorphism in the XPG gene, and tumour stage, grade, and clinical course in patients with nonmuscle-invasive neoplasms of the urinary bladderBJU Int200697484785116536785
   PubMed Web of Science ®Google Scholar
• LiuXZhangZDengCTianYMaXMeta-analysis showing that ERCC1 polymorphism is predictive of osteosarcoma prognosisOncotarget2017837627696277928977987
   PubMedGoogle Scholar
• LiuDWuJShiGYZhouHFYuYRole of XRCC1 and ERCC5 polymorphisms on clinical outcomes in advanced non-small cell lung cancerGenet Mol Res20141323100310724782167
   PubMed Web of Science ®Google Scholar
• SchramaDSchererDSchneiderMERCC5 p.Asp1104His and ERCC2 p.Lys751Gln polymorphisms are independent prognostic factors for the clinical course of melanomaJ Invest Dermatol201113161280129021390047
   PubMed Web of Science ®Google Scholar
• LiJLiuSWangWERCC polymorphisms and prognosis of patients with osteosarcomaTumour Biol20143510101291013625023406
   PubMedGoogle Scholar
• BaiSBChenHXBaoYXLuoXZhongJJPredictive impact of common variations in DNA repair genes on clinical outcome of osteosarcomaAsian Pac J Cancer Prev20131463677368023886164
   PubMedGoogle Scholar
• SunXHHouWGZhaoHXZhaoYLMaCLiuYSingle nucleotide polymorphisms in the NER pathway and clinical outcome of patients with bone malignant tumorsAsian Pac J Cancer Prev20131432049205223679317
   PubMedGoogle Scholar
• NegandhiAAHydeADicksEMTHFR Glu429Ala and ERCC5 His46His polymorphisms are associated with prognosis in colorectal cancer patients: analysis of two independent cohorts from NewfoundlandPLoS One201384e6146923626689
   PubMed Web of Science ®Google Scholar
• WangFZhangSDXuHMXPG rs2296147 T>C polymorphism predicted clinical outcome in colorectal cancerOncotarget2016710117241173226887052
   PubMedGoogle Scholar
• LiuDWuHZZhangYNDNA repair genes XPC, XPG polymorphisms: relation to the risk of colorectal carcinoma and therapeutic outcome with oxaliplatin-based adjuvant chemotherapyMol Carcinog201251Suppl 1E83E9322213216
   PubMedGoogle Scholar
• ChenJLuoXXieGFunctional analysis of SNPs in the ERCC5 promoter in advanced colorectal cancer patients treated with oxaliplatin-based chemotherapyMedicine20169519e365227175691
   PubMed Web of Science ®Google Scholar
• SunKGongALiangPPredictive impact of genetic polymorphisms in DNA repair genes on susceptibility and therapeutic outcomes to colorectal cancer patientsTumour Biol20153631549155925355595
   PubMedGoogle Scholar
• HuWPanJZhaoPYangGYangSGenetic polymorphisms in XPG could predict clinical outcome of platinum-based chemotherapy for advanced non-small cell lung cancerTumour Biol20143565561556724615519
   PubMedGoogle Scholar
• JinZYZhaoXTZhangLNWangYYueWTXuSFEffects of polymorphisms in the XRCC1, XRCC3, and XPG genes on clinical outcomes of platinum-based chemotherapy for treatment of non-small cell lung cancerGenet Mol Res20141337617762524737519
   PubMed Web of Science ®Google Scholar
• HeCDuanZLiPXuQYuanYRole of ERCC5 promoter polymorphisms in response to platinum-based chemotherapy in patients with advanced non-small-cell lung cancerAnticancer Drugs201324330030523211354
   PubMed Web of Science ®Google Scholar
• ZhangTSunJLvMXPG is predictive gene of clinical outcome in advanced non-small-cell lung cancer with platinum drug therapyAsian Pac J Cancer Prev201314270170523621222
   PubMedGoogle Scholar
• JeongYHLeeCKJoKCorrelation analysis and prognostic impact of (18)F-FDG PET and excision repair cross-complementation group 1 (ERCC-1) expression in non-small cell lung cancerNucl Med Mol Imaging201549210811426085855
   PubMedGoogle Scholar